Exagen (XGN)
(Delayed Data from NSDQ)
$2.95 USD
-0.13 (-4.22%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $2.92 -0.03 (-1.02%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth F Momentum C VGM
Income Statements
Fiscal Year end for Exagen Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 53 | 46 | 48 | 42 | 40 |
Cost Of Goods | 23 | 24 | 21 | 17 | 19 |
Gross Profit | 29 | 21 | 28 | 25 | 22 |
Selling & Adminstrative & Depr. & Amort Expenses | 52 | 67 | 52 | 41 | 31 |
Income After Depreciation & Amortization | -23 | -46 | -24 | -15 | -9 |
Non-Operating Income | 2 | 1 | 0 | 1 | 1 |
Interest Expense | 2 | 2 | 3 | 3 | 3 |
Pretax Income | -24 | -48 | -27 | -17 | -12 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -24 | -47 | -27 | -17 | -12 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -24 | -47 | -27 | -17 | -12 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -21 | -39 | -23 | -14 | -8 |
Depreciation & Amortization (Cash Flow) | 2 | 7 | 1 | 1 | 1 |
Income After Depreciation & Amortization | -23 | -46 | -24 | -15 | -9 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 17.68 | 17.08 | 15.97 | 12.63 | 3.58 |
Diluted EPS Before Non-Recurring Items | -1.34 | -2.52 | -1.68 | -1.32 | -8.46 |
Diluted Net EPS (GAAP) | -1.34 | -2.77 | -1.68 | -1.32 | -8.46 |
Fiscal Year end for Exagen Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 15.06 | 14.42 | 13.77 | 13.42 | 14.14 |
Cost Of Goods | 6.01 | 5.82 | 5.62 | 5.71 | 5.84 |
Gross Profit | 9.06 | 8.60 | 8.15 | 7.71 | 8.30 |
SG&A, R&D, and Dept/Amort Expenses | 11.64 | 11.60 | 13.30 | 12.78 | 13.21 |
Income After SG&A, R&D, and Dept/Amort Expenses | -2.58 | -3.00 | -5.15 | -5.07 | -4.91 |
Non-Operating Income | 0.18 | 0.19 | 0.86 | 0.21 | 0.48 |
Interest Expense | 0.56 | 0.55 | 0.57 | 0.56 | 0.57 |
Pretax Income | -2.97 | -3.36 | -5.54 | -5.42 | -5.01 |
Income Taxes | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -2.97 | -3.36 | -5.57 | -5.42 | -5.01 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -2.97 | -3.36 | -5.57 | -5.42 | -5.01 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 18.18 | 17.94 | 17.84 | 17.69 | 17.66 |
Diluted EPS Before Non-Recurring Items | -0.16 | -0.19 | -0.31 | -0.31 | -0.28 |
Diluted Net EPS (GAAP) | -0.16 | -0.19 | -0.31 | -0.31 | -0.28 |